This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

NeilMccloyd: - May I?
The "3-treatments" are (in reality) three Streams , = dreams - each becomming several "products", Each "product" requires a huge investment to get through trials/pass regulation/into sales.
- - - Oh, and finally they need a sales Partner. More pressing, they need CASH as well as a Parner to bankroll the PhaseIII trials in a few years time. Trials are notoriously expensive (something like $20m, but it could be pounds, the number is so big). Plus "time" - I recall Oxford Bio took 10-years and not one product is through!(Although OXB has not had any serious setbacks)
MMI is certainly "interesting" - but that is all - yes I agree the Salary looks very steep, esp. in view of their cash position (= under 10m, probably as low as 1m)

So where does that leave the value to shareholders, who are unlikely to want ( or be able), to cough up 20m for each product -
Dunno - for whichever product they go with, there are risks and the one product you can't make is "time" - that's what they ran out of - had they had more time (before the bubble burst) they would still be here, telling everyone it's worth 's.
Well, it ain't - the issue (now), is what is anyone prepared to invest? Would shareholders cough up 50p/share (to raise 20m-ish).....anyone that holds say 5k-worth at 1 =5000 will have lost 4k(today), yet need to find about 2500 -
Could investors be willing......? Maybe under certain conditions, like the Management is Bio-background and is rewarded as the Trials go forward, with the enphasis on keeping cash-spend low. The past-management is no longer an issue - they have no place IMHO, moving the company into the Medico Trials Arena.

Were there tell-tale signs?
1) The company name was a bit OTT, considering they didn't sell anything.
2) They didn't invent the products - they have some arrangement with a University, which is far from made clear
3) In nearly 8-years no phase trials had been concluded, nor a partner found for products that were (told to punters), world-class life-enhancing curatives.
(DYOR - anyone disagree?)

Anyone here, willing to invest ots to resolve [MMG] funding?
I wonder.
(or-= alternative views!)

So there it is DB and MM both sacked and the sp recovers where do we go from here.

The 2 wasters of MMG will be terminated...may their souls rest in peace!

Free section Michael Walters - 'The Battle for MMG'

http://www.michaelwalters.com/stories/news.phtml?num=3145

Sp rising, as earlier investors average down - but I suspect we'll see a massive placing and the spectre of Bankers taking a big chunk; such was the cash mis-management by The Fallen.
Of course it could have all been different, if Money-markets were like three years ago - that was the time when they should have taken whatever they could, but I suspect Execs didn't like the Terms.
Meanwhile the storm-clouds gathered as Money became tight, even though the limited Trials were on-going. However, their trials are not far-enough along to create real value, er IMHO.
Meeting 15 April 08 should be "exciting"

Good riddance to these two tossers...


Medical Marketing says directors David Best, Margaret Mitchell resign - AFX

LONDON (Thomson Financial) - Life sciences company Medical Marketing International Group PLC. said the company's founders, David Best and Margaret Mitchell, resigned as directors of the company with immediate effect, on April 14.

A meeting had been convened for Tuesday which would have proposed Best and Mitchell's removal.

Last month Medical Marketing International's new non-executive chairman Phil Cartmell announced that along with the company's board he had terminated the contract of managing director David best, and his wife, IT director Margaret Mitchell.

Best, who was on long-term sick leave with his wife, was the target of a shareholder-backed boardroom coup in February after institutional shareholders and board members appointed Cartmell to examine the make-up of the board and resolve a leadership dispute.

At the end of the company's financial year 2007, Best, who was also the former chairman of the company, and his wife owned between them 32.63 pct of the company.

tf.TFN-Europe_newsdesk@thomson.com

slm

Yes Meeting was exciting alright.

All pretty quiet, eh?
I see the sp is limping along at 20p-ish.
Is there a "strategic review" in progress?

-OR-
What Next?

It was only a few months ago this stock was over 1, representing an 80% loss. I'm guessing they will increase the shares with a Placing, to improve the holding-power of the Institutional investors. This might be one way to reduce the Voting-power of the Bests.

Over 12 months ago they knew Cash was running out - but I guess D.B was "hopeful" something would turn-up. Unfortunately he had no fall-back position and no "deal" materialised.
FWIW... as I see it, the 3-platforms aren't worth much, as they aren't very far along the Phase-trials.....although they have had lots of investor-money spent - in the main, it seems it was salaries to the Bests . . . . . . . oh deary!

EDIT Aug08-
Down to 12p although a recent "review" was as upbeat as situation allowed and Prudential increased their stake. If there is a Placing, it will be at pennies and Loyal Punters will be severely diluted as many paid 1 +
EDIT 02Sept08-
Down to 11/12p (-8%), on zero volume so far. Placing at 5p maybe soon?

Game over it seems.............

Money is too tight to mention never mind with MMG.

Bad luck guys.

Hi hangon what are your thoughts here bearing in mind the current price and that biotech is out of favor at the moment

Now MOVING up.

And down again.

End of the road soon.

FWIW the issue is the previous Exec shareholding.
Unfortunately the law allows ex-execs to shackle the reigning Execs, by blocking votes and so on.
This is not in the interest of shareholders who bought on the open market and should be made illegal.
The shareholding is considerably less valuable that earlier, due to their lack of stewardship (and maybe other reasons) so by any logic they are feeling considerable pain as the shares slip.

They are hoping to revive the company and maybe return to the fold, but I suspect the real value is lacking and this business is unfit for purpose as structured. The proposed change of name to OncoScience is also a very poor choice, although it is almost at zero-cost.

I suspect this will fall further as mitzy suggests, there being no future until the share-ownership (problem) is removed.
Any other views?

Agree there hangon the company is going nowhere until the Bests shareholding position is resolved..I'm not holding my breath.

Seems outrageous to me that a relatively small holder ( esp one running the business for much of the failing Mkt cap) -can effectivly create a stalemate, until their demands are met ( my words)....whatever they are, eh?
Seems to me the Co needs to go to the High Court and get a ruling that allows progress without fearing a block-vote from the Bests.
Alternatively the Court might put a value on the Bests' holding as if nothing is done, based on the falling SP over the last few months.
Given that "doing nothing" will effectivly kill the business, it's about time the Bests bowed-out and took a relativly small % so that other investors can get on with the Business.
FWIW I suggest total take up of 9% of the new company, or 10% if the shares are stripped of their voting-rights. (Upon sale, the voting rights would be restored)
Frankly, considering the buiness is worth sod-all (now), that's a pretty good offer if the business survives, but the longer this goes on the greater the risk it will fail all-together.
(Bests had their turn for 10+ years and look at the results - it's barely further ahead that at the start.....and the cash is all spent, mostly on the Bests' income )

!!!.What a waste of time and (retail-)shareholder-money.!!!

Grr.

EDIT: It seems just one day later (30Sept, see RNS) MMG has done a deal over their research centre in Cambridge, in effect a large millstone has been replaced by two smaller millstones, with payments of 100k right now and another 100k in 2009.....ooer, I wonder if there are other Lock-in problems created by the previous Management?....all this adds up to woeful business activity.
All IMHO, DYOR, this is not a clear story.

I have placed a limit order @3p.

Attention:

Nearly 1 mill shares traded today...

.......

gf you in...?

Heard gf had retired